{
  "id": 9592205,
  "title": "XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration",
  "url": "https://urgent.news/2026/09/24/xlv-vs-ibb-how-healthcare-diversification-compares-to-biotech-9592205",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T15:43:56.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/etfs/2026/09/24/xlv-vs-ibb-how-healthcare-diversification-compares-to-biotech-concentration/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration",
        "url": "https://urgent.news/2026/09/24/xlv-vs-ibb-how-healthcare-diversification-compares-to-biotech",
        "published": "2026-09-24T16:03:56.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}